Teva Pharmaceutical

This weekend's Barron's cover story suggests how to play the streaming TV revolution. Other featured articles discuss the effect of lower enterprise tech spending and offer dividend stock picks for a low-rate world. Also, the prospects for an oil giant, an optical retailer, a beleaguered...

Benzinga has examined prospects for many investor favorite stocks over the past week. Bullish calls included two recent high-profile IPOs and a financial giant. Bearish calls included the iPhone maker, an EV startup and a specialty retailer. May, a month in the shadow of trade concerns, ended...

Benzinga has featured looks at many investor favorite stocks over the past week. Bullish calls included entertainment and retail giants. Bearish calls included some iconic names as well The big news of the past week was, of course, the outcome of the midterm elections, followed by speculation on...

Insider buying can be an encouraging signal for potential investors. The CEO of the leading electric vehicle maker put his money where his mouth is this week. A couple of 10 percent owners notably increased their stakes as well. Conventional wisdom says that insiders and 10 percent...

Benzinga has featured a look at many investor favorite stocks over the past week. Bullish calls featured giants in the consumer electronics and entertainment arenas. Bearish calls included discount retailers and a social media leaders. The new year is off to a strong start in the equity...

U.S. stocks rallied to start the week on a positive note. Investors are looking for bullish signs that can erase last weeks declines, as the S&P 500 had its largest weekly drop since 2012 and the Volatility Index surged more than 30 percent. Portugal's Central Bank plans to spend 4.9...

Leading generic drug maker Teva Pharmaceutical (NYSE: TEVA) posted better than expected earnings last week and raised its full-year profit forecast. There was plenty for investors to be concerned about, though. Sales of its best-selling product, Copaxone, were down for the quarter, and activist...

Analysts believe that Medtronic (NYSE: MDT), Teva Pharmaceuticals (NYSE: TEVA), UnitedHealth Group (NYSE: UNH) and Zimmer Holdings (NYSE: ZMH) shares still have some headroom, though they all have handily outperformed the S&P 500 over the past six months. They are all dividend payers as well....

U.S. stocks were higher on Friday, marking the third consecutive week of gains. Investors cheered May's job report which showed a slow and steady improvement in the labor market. Continuing the trend set in recent trading sessions, the Dow Jones Industrial Average and S&P 500 index...

U.S. stocks were lower with the S&P 500, Dow Jones and Nasdaq indices all ending in the red. In a lackluster trading session with little market moving move, investors are likely sitting on the sidelines until key data will be released later on this week. All eyes will be on Friday's...

While Amgen (NASDAQ: AMGN) saw a sizable dip in short interest between the April 30 and May 15 settlement dates, short sellers piled on Medivation (NASDAQ: MDVN) and Pharmacyclics (NASDAQ: PCYC). Among other leading biotechs and emerging pharmaceuticals, gains in the number of their shares sold...

U.S. stocks declined for the second straight day after investors and traders digested disappointing earnings from retailers and economic reports were disappointing. The Dow suffered a triple-digit point loss and declined one percent after the retailer giant Wal-Mart failed to "wow" investors....

U.S. stocks were mixed as the Dow finished in positive territory and the S&P 500 index turned negative after rising to within two points of its record close. The Nasdaq also turned negative towards the end of the day, declining for the third straight day. Earnings continue to come in mixed...

U.S. stocks were little moved to start off the month of May as investors and traders are cautious before April's nonfarm payrolls report are released on Friday. The consensus estimate for Friday's figure stands at 215,000 which would trump March's 192,000 number. “This is a really important...